pcDNA3.1-TYMS Citations (2)
Originally described in: Pyrimidine metabolic rate limiting enzymes in poorly-differentiated hepatocellular carcinoma are signature genes of cancer stemness and associated with poor prognosis.Yeh HW, Lee SS, Chang CY, Hu CM, Jou YS Oncotarget. 2017 Sep 8;8(44):77734-77751. doi: 10.18632/oncotarget.20774. eCollection 2017 Sep 29. PubMed Journal
Articles Citing pcDNA3.1-TYMS
| Articles |
|---|
Pyrimidine metabolic rate limiting enzymes in poorly-differentiated hepatocellular carcinoma are signature genes of cancer stemness and associated with poor prognosis.
Yeh HW, Lee SS, Chang CY, Hu CM, Jou YS.
Oncotarget. 2017 Sep 8;8(44):77734-77751. doi: 10.18632/oncotarget.20774. eCollection 2017 Sep 29.
PubMed
Associated Plasmids |
| Mitochondrial and Cytosolic One-Carbon Metabolism Is a Targetable Metabolic Vulnerability in Cisplatin-Resistant Ovarian Cancer. Wallace-Povirk A, O'Connor C, Dekhne AS, Bao X, Nayeen MJ, Schneider M, Katinas JM, Wong-Roushar J, Kim S, Polin L, Li J, Back JB, Dann CE 3rd, Gangjee A, Hou Z, Matherly LH. Mol Cancer Ther. 2024 Jun 4;23(6):809-822. doi: 10.1158/1535-7163.MCT-23-0550. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.